Finance

Lists
Why is ODTX down 13.00%?
Dive Deeper
ODTX:NASDAQ
Odyssey Therapeutics Inc
$18.13
-13.00%
(-2.71) 1D
$18.39
+1.43% (+0.26)
After hours
Closed: Oct 6, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ODTX...
Open
$20.84
High
$20.84
Low
$18.06
Mkt. cap
866.49M
Avg. vol.
333.30K
Volume
0.00
52-wk high
$29.05
52-wk low
$15.10
EPS
-$4.02
No. of employees
100
Open
$20.84
High
$20.84
Low
$18.06
Mkt. cap
866.49M
Avg. vol.
333.30K
Volume
0.00
52-wk high
$29.05
52-wk low
$15.10
EPS
-$4.02
No. of employees
100
News stories
From web sources and news partners
About Odyssey Therapeutics Inc
CEO-
Employees100
Founded2021
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteodysseytx.com
Analyst ratings
Based on 4 analysts giving stock ratings to ODTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ODTX in the last 3 months.
Highest
Current $18.13
$44.00 (+142.69%)
Average
$34.33 (+89.35%)
Lowest
$29.00 (+59.96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$44.00
+142.7%
09/21/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/11/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
$29.00
+60%
08/10/2026
David Nierengarten
Wedbush
Buy
Maintained
$30.00
+65.5%
08/05/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
$40.00
+120.6%
06/18/2026
Eric Schmidt FCA
Cantor Fitzgerald
Buy
Initiated
-
-
06/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
1.92M
959.00K
-
-
Cost of goods sold
-
30.23M
-
36.23M
Cost of revenue
-
30.23M
-
36.23M
Research and development expenses
38.77M
-
32.32M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.95M
13.22M
7.35M
10.51M
Operating expense
46.73M
13.22M
39.67M
10.51M
Total operating expenses
46.73M
43.45M
39.67M
46.74M
Operating income
-44.81M
-42.49M
-39.67M
-46.74M
Other non operating income
-289.00K
-154.00K
-117.00K
-138.00K
EBT including unusual items
-38.30M
-41.20M
-38.20M
-52.80M
EBT excluding unusual items
-43.94M
-41.77M
-38.09M
-44.06M
Income tax expense
140.00K
30.00K
63.00K
-8.00K
Effective tax rate
-0.37%
-0.07%
-0.16%
0.02%
Other operating expenses
-
-
-
-
Net income
-38.44M
-41.24M
-38.26M
-52.79M
Net profit margin
-2,003.91%
-4,299.79%
-
-
Earnings per share
-
-
-6.75
-1.27
Interest and investment income
1.16M
872.00K
1.71M
2.83M
Interest expense
-2.00K
-2.00K
-10.00K
-20.00K
Net interest expenses
1.15M
870.00K
1.70M
2.81M
Depreciation and amortization charges
-
-
-
-
EBITDA
-43.51M
-41.22M
-38.50M
-45.69M
Gain or loss from assets sale
495.00K
-115.00K
-33.00K
639.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps